5-bromo-8-methoxy-3-methyl-3,4-dihydronaphthalen-1(2H)-one | 91720-95-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 5-bromo-8-methoxy-3-methyl-3,4-dihydronaphthalen-1(2H)-one
• 英文别名: 5-Brom-8-methoxy-3-methyl-1-tetralon；5-Brom-8-methoxy-1-oxo-3-methyl-1.2.3.4-tetrahydro-naphthalin；5-Bromo-8-methoxy-3-methyl-1,2,3,4-tetrahydronaphthalen-1-one；5-bromo-8-methoxy-3-methyl-3,4-dihydro-2H-naphthalen-1-one
• CAS: 91720-95-5
• 化学式: C₁₂H₁₃BrO₂
• 分子量: 269.138
• InChiKey: DSJRSKUSGKBVNH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-bromo-8-methoxy-3-methyl-3,4-dihydronaphthalen-1(2H)-one 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 生成 5-Brom-8-hydroxy-1-oxo-3-methyl-1.2.3.4-tetrahydro-naphthalin
  参考文献：
  名称：

  3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of α5-containing GABAA receptors

  摘要：

  A series of substituted 3,4-dihydronaphthalen-1(2H)-ones with high binding affinity for the benzodiazepine site of GABA(A) receptors containing the alpha5-subunit has been identified. These compounds have consistently higher binding affinity for the GABA(A) alpha5 receptor subtype over the other benzodiazepine-sensitive GABA(A) receptor subtypes (alpha1, alpha2 and alpha3). Compounds with a range of efficacies for the benzodiazepine site of alpha5-containing GABA(A) receptors were identified, including the alpha5 inverse agonist 3,3-dimethyl-8-methylthio-5-(pyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 22 and the alpha5 agonist 8-ethylthio-3-methyl-5-(1-oxidopyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 19. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.054
• 作为产物：
  描述：

  4-<2-Brom-5-methoxy-phenyl>-3-methyl-buttersaeure 、 五氯化磷 、 四氯化锡 以67%的产率得到
  参考文献：
  名称：

  NISHIYAMA, TAKEO;KAMEOKA, HIROMU, CHEM. EXPRESS , 6,(1991) N, C. 109-112

  摘要：

  DOI：

文献信息

• Substituted tetralone derivatives for enhancing cognition
  申请人：Merck Sharpe & Dohme Limited

  公开号：US06156761A1

  公开（公告）日：2000-12-05

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein A, B, R2, R3 and q are as defined in the disclosure, pharmaceutical compositions containing them; methods for their production; their use in therapy and methods of treatment of disease states where cognition enhancement is required, such as Alzheimer's disease.

  本发明提供了式(I)的化合物或其药学上可接受的盐：##STR1## 其中A、B、R2、R3和q如本文所定义，以及包含它们的药物组成物；它们的制备方法；它们在治疗中的用途和治疗需要认知增强的疾病状态的方法，例如阿尔茨海默病。
• NISHIYAMA, TAKEO;KAMEOKA, HIROMU, CHEM. EXPRESS , 6,(1991) N, C. 109-112
  作者：NISHIYAMA, TAKEO、KAMEOKA, HIROMU

  DOI：——

  日期：——
• US6156761A
  申请人：——

  公开号：US6156761A

  公开（公告）日：2000-12-05
• 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of α5-containing GABAA receptors
  作者：Helen J. Szekeres、John R. Atack、Mark S. Chambers、Susan M. Cook、Alison J. Macaulay、Gopalan V. Pillai、Angus M. MacLeod

  DOI：10.1016/j.bmcl.2004.03.054

  日期：2004.6

  A series of substituted 3,4-dihydronaphthalen-1(2H)-ones with high binding affinity for the benzodiazepine site of GABA(A) receptors containing the alpha5-subunit has been identified. These compounds have consistently higher binding affinity for the GABA(A) alpha5 receptor subtype over the other benzodiazepine-sensitive GABA(A) receptor subtypes (alpha1, alpha2 and alpha3). Compounds with a range of efficacies for the benzodiazepine site of alpha5-containing GABA(A) receptors were identified, including the alpha5 inverse agonist 3,3-dimethyl-8-methylthio-5-(pyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 22 and the alpha5 agonist 8-ethylthio-3-methyl-5-(1-oxidopyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 19. (C) 2004 Elsevier Ltd. All rights reserved.